CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $63,004 | +215.0% | 570,168 | +366.7% | 0.00% | – |
Q3 2022 | $20,000 | +5.3% | 122,166 | +59.6% | 0.00% | – |
Q2 2022 | $19,000 | -82.2% | 76,567 | -27.0% | 0.00% | – |
Q3 2021 | $107,000 | -93.2% | 104,819 | -44.4% | 0.00% | -100.0% |
Q2 2020 | $1,580,000 | – | 188,372 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |